Skynor Medical（Shanghai）Co.,Ltd

Skynor Medical（Shanghai）Co.,Ltd primarily manufactures a series of Hydrus devices, which are likely intended for central and peripheral vascular interventions. The company also produces the SkyLoach product. Based on the device names and classifications, these devices are designed for procedures involving blood vessels, such as stenting or occlusion treatments.

Skynor Medical（Shanghai）Co.,Ltd is headquartered in Shanghai, China. The company operates within a facility that includes office, research and development, and production spaces, ensuring compliance with relevant regulatory standards.

Skynor Medical’s devices are listed in the eudamed database, which is the European Union’s central registry for medical devices. This registry is used to track devices that have undergone conformity assessment procedures under EU regulations.

Skynor Medical’s devices are classified as Class III and Class IIa under EU medical device regulations. Class III devices are typically high-risk, such as those used in life-supporting or life-sustaining procedures, while Class IIa devices pose moderate risks. The classification determines the regulatory requirements for market authorization, such as clinical evaluations and conformity assessment procedures.